Western blot - Axl antibody - C-terminal (ab72069)
Anti-Axl antibody - C-terminal (ab72069) at 1/100 dilution + SKBR3 cell lysate at 12.5 µg
Predicted band size : 98 kDa Observed band size : 98 kDa Additional bands at : 25 kDa,37 kDa,50 kDa. We are unsure as to the identity of these extra bands.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Axl antibody - C-terminal (ab72069)
ab72069 at 1/50 dilution, staining Axl in human breast carcinoma by Immunohistochemistry using formalin-fixed, paraffin-embedded tissue, followed by peroxidase-conjugated secondary antibody and DAB staining.
Dine JL et al. The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. Breast Cancer Res Treat155:235-51 (2016).
Read more (PubMed: 26759246) »
Leconet W et al. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. OncogeneN/A:N/A (2013).
Read more (PubMed: 24240689) »